Literature DB >> 11837698

Transport activity of human MRP3 expressed in Sf9 cells: comparative studies with rat MRP3.

Hidetaka Akita1, Hiroshi Suzuki, Tomoko Hirohashi, Hajime Takikawa, Yuichi Sugiyama.   

Abstract

PURPOSE: Multidrug resistance-associated protein 3 (MRP3) was initially cloned as a hepatic transporter induced under cholestatic/ hyperbilirubinemic conditions. In the present study, transport property of human MRP3 (hMRP3) was compared with that of rat MRP3 (rMRP3).
METHODS: Adenosine 5' triphosphate (ATP)-dependent uptake of several organic anions into the membrane vesicles isolated from the Sf9 cells expressing hMRP3 and rMRP3 was measured by rapid filtration technique.
RESULTS: ATP-dependent uptake of glucuronide conjugates, glutathione conjugates. and [3H]methotrexate (MTX) was stimulated by infection of cDNAs for hMRP3 and rMRP3. The mean (+/- SE) Km values for the uptake of 17beta estradiol 17beta-D-glucuronide ([3H]E(2)17 betaG) by hMRP3 and rMRP3 were 42.9 +/- 4.3 microM and 33.4 +/- 2.2 microM, respectively. Although the Ki values of glucuronides on the uptake of E217betaG were similar in humans and rats, hMRP3 exhibited higher Ki values toward MTX. In addition, although glycocholate and taurolithocholate 3-sulfate (TLC-S) were transported by both hMRP3 and rMRP3, taurocholate was only transported to a significant degree by rMRP3. Moreover, the inhibitory effect of taurocholate and glycocholate on the transport of E(2)17beta3G was much more potent in rMRP3 compared to hMRP3.
CONCLUSION: Collectively, the substrate specificity of hMRP3 resembles that of rMRP3 although differences were observed, particularly in bile acid transport.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11837698     DOI: 10.1023/a:1013699130991

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  25 in total

Review 1.  Molecular aspects of hepatobiliary transport.

Authors:  M Müller; P L Jansen
Journal:  Am J Physiol       Date:  1997-06

Review 2.  Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport.

Authors:  R P Oude Elferink; D K Meijer; F Kuipers; P L Jansen; A K Groen; G M Groothuis
Journal:  Biochim Biophys Acta       Date:  1995-07-17

Review 3.  Multidrug resistant proteins.

Authors:  P Borst
Journal:  Semin Cancer Biol       Date:  1997-06       Impact factor: 15.707

4.  Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane.

Authors:  J König; D Rost; Y Cui; D Keppler
Journal:  Hepatology       Date:  1999-04       Impact factor: 17.425

5.  A single amino acid residue contributes to distinct mechanisms of inhibition of the human multidrug transporter by stereoisomers of the dopamine receptor antagonist flupentixol.

Authors:  S Dey; P Hafkemeyer; I Pastan; M M Gottesman
Journal:  Biochemistry       Date:  1999-05-18       Impact factor: 3.162

6.  Characterization of inducible nature of MRP3 in rat liver.

Authors:  K Ogawa; H Suzuki; T Hirohashi; T Ishikawa; P J Meier; K Hirose; T Akizawa; M Yoshioka; Y Sugiyama
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-03       Impact factor: 4.052

7.  Transport of amphipathic anions by human multidrug resistance protein 3.

Authors:  H Zeng; G Liu; P A Rea; G D Kruh
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

8.  Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver.

Authors:  C J Soroka; J M Lee; F Azzaroli; J L Boyer
Journal:  Hepatology       Date:  2001-04       Impact factor: 17.425

9.  Mechanism of glutathione S-conjugate transport in canalicular and basolateral rat liver plasma membranes.

Authors:  K Kobayashi; Y Sogame; H Hara; K Hayashi
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

10.  Diabetes-induced bile acid composition changes in rat bile determined by high performance liquid chromatography.

Authors:  Y Siow; A Schurr; G C Vitale
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

View more
  22 in total

Review 1.  New perspectives for the treatment of cholestasis: lessons from basic science applied clinically.

Authors:  James L Boyer
Journal:  J Hepatol       Date:  2006-12-18       Impact factor: 25.083

2.  Nuclear receptors RXRalpha:RARalpha are repressors for human MRP3 expression.

Authors:  Wensheng Chen; Shi-Ying Cai; Shuhua Xu; Lee A Denson; Carol J Soroka; James L Boyer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-02-01       Impact factor: 4.052

Review 3.  A perspective on efflux transport proteins in the liver.

Authors:  K Köck; K L R Brouwer
Journal:  Clin Pharmacol Ther       Date:  2012-09-05       Impact factor: 6.875

Review 4.  An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters.

Authors:  Kyunghee Yang; Kathleen Köck; Alexander Sedykh; Alexander Tropsha; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2013-05-07       Impact factor: 3.534

5.  Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-signaling pathway.

Authors:  Jin Chai; Yu He; Shi-Ying Cai; Zhongyong Jiang; Huaizhi Wang; Qiong Li; Lei Chen; Zhihong Peng; Xiaochong He; Xiaoping Wu; Tianli Xiao; Rongquan Wang; James L Boyer; Wensheng Chen
Journal:  Hepatology       Date:  2012-05       Impact factor: 17.425

Review 6.  Placental ABC Transporters: Biological Impact and Pharmaceutical Significance.

Authors:  Anand A Joshi; Soniya S Vaidya; Marie V St-Pierre; Andrei M Mikheev; Kelly E Desino; Abner N Nyandege; Kenneth L Audus; Jashvant D Unadkat; Phillip M Gerk
Journal:  Pharm Res       Date:  2016-09-19       Impact factor: 4.200

7.  Prediction of Altered Bile Acid Disposition Due to Inhibition of Multiple Transporters: An Integrated Approach Using Sandwich-Cultured Hepatocytes, Mechanistic Modeling, and Simulation.

Authors:  Cen Guo; Kyunghee Yang; Kenneth R Brouwer; Robert L St Claire; Kim L R Brouwer
Journal:  J Pharmacol Exp Ther       Date:  2016-05-27       Impact factor: 4.030

8.  Treatment of hyperbilirubinemia in Eisai hyperbilirubinemic rat by transfecting human MRP2/ABCC2 gene.

Authors:  Masakazu Hirouchi; Hiroshi Suzuki; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2005-04-07       Impact factor: 4.200

9.  Repression of hepatobiliary transporters and differential regulation of classic and alternative bile acid pathways in mice during pregnancy.

Authors:  Lauren M Aleksunes; Ronnie L Yeager; Xia Wen; Julia Yue Cui; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2012-08-17       Impact factor: 4.849

10.  MRP3: a molecular target for human glioblastoma multiforme immunotherapy.

Authors:  Chien-Tsun Kuan; Kenji Wakiya; James E Herndon; Eric S Lipp; Charles N Pegram; Gregory J Riggins; Ahmed Rasheed; Scott E Szafranski; Roger E McLendon; Carol J Wikstrand; Darell D Bigner
Journal:  BMC Cancer       Date:  2010-09-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.